Target

N/A

Donor:

Novo Nordisk Pharma S.A.R.L

Budget:

100,000 USD

Duration:

October 2023 - October 2026

Novo Nordisk Health 23-26

Bring Societal Changes to Support Underprivileged Patients Living with Diabetes in Lebanon